US Broker Ratings

Merus N.V. (MRUS) Stock Analysis: Biotechnology Gem with 7.78% Potential Upside

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, stands at a pivotal point in its growth trajectory. Specializing in the development of innovative antibody therapeutics, Merus is making waves in..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 69.81% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a key player in the biotechnology sector, is garnering significant attention from investors, thanks to its promising pipeline and substantial growth potential. With a current market..

Perrigo Company plc (PRGO): Valuation Insights Reveal Significant 44% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, stands out in the drug manufacturing industry with its focus on over-the-counter health and wellness solutions. Headquartered in..

Disc Medicine, Inc. (IRON) Stock Report: Analyst Consensus Predicts 84.84% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention in the healthcare sector for its innovative focus on hematologic diseases. Headquartered in Watertown, Massachusetts, Disc Medicine is..

NeoGenomics, Inc. (NEO) Investor Outlook: Assessing the 27.97% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) stands as a noteworthy contender within the healthcare sector, specifically in the diagnostics and research industry. With a current market capitalization of $1.47 billion and operating..

Pediatrix Medical Group (MD) Stock Analysis: Exploring Growth Potential and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the medical care facilities industry, holds a distinctive position within the healthcare sector. With a market capitalization of $1.87 billion,..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 42.84% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) emerges as a compelling opportunity within the healthcare sector, particularly in the high-demand sphere of specialty and generic drug manufacturing. With a market capitalization of..

Evotec SE (EVO) Stock Analysis: Navigating a 60% Potential Upside in the Healthcare Sector

Investors keen on the healthcare sector might find Evotec SE (EVO) an intriguing prospect, particularly given its substantial potential upside of 60.43%. Operating out of Germany, this drug discovery and..

Liquidia Corporation (LQDA) Stock Analysis: Exploring 1,121.70% Revenue Growth and Strategic Opportunities

Liquidia Corporation (NASDAQ: LQDA) is capturing investor attention with its impressive 1,121.70% revenue growth, positioning itself as a notable player in the biotechnology sector. Headquartered in Morrisville, North Carolina, Liquidia..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 21% Upside Potential Beckons Investors

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, specifically in the medical care facilities industry, offers investors a compelling opportunity with a potential upside of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 54% Potential Upside Amidst Robust Buy Ratings

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company headquartered in South San Francisco, California, is capturing investor attention with a compelling potential upside of 54.09%. As the company..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 36% Upside in the Biotechnology Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands at the forefront of innovative biopharmaceutical research, specializing in the discovery and development of cellular metabolism therapies. With a market capitalization of $1.64 billion,..

Integra LifeSciences Holdings C (IART) Investor Outlook: Analyzing a 36.93% Potential Upside in the Medical Device Sector

As a player in the competitive medical device industry, Integra LifeSciences Holdings Corporation (NASDAQ: IART) has caught the attention of investors seeking opportunities in the healthcare sector. With a market..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a 6.43% Potential Upside in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG), a leading player in the health information services industry, is making waves with its cutting-edge technology that revolutionizes the analysis of biological systems. Headquartered in..

Innoviva, Inc. (INVA) Stock Analysis: Potential 43% Upside Captivates Investors

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, has been drawing attention from investors due to its impressive growth potential and strategic focus on innovative pharmaceutical products...

Azenta, Inc. (AZTA) Stock Analysis: Is a 35.10% Potential Upside Worth Considering?

Azenta, Inc. (NASDAQ: AZTA) is carving a niche in the healthcare sector with its innovative solutions in the medical instruments & supplies industry. Headquartered in Burlington, Massachusetts, Azenta stands out..

Twist Bioscience Corporation (TWST) Stock Analysis: A Promising Play in Synthetic DNA with 16.9% Revenue Growth

Twist Bioscience Corporation (NASDAQ: TWST) is attracting attention in the healthcare sector with its innovative approach to synthetic DNA-based products. Operating in the diagnostics and research industry, Twist Bioscience is..

Opko Health, Inc. (OPK) Investor Outlook: Unpacking the 189.30% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a name that resonates within the healthcare sector, has captured the attention of investors with its promising potential upside of 189.30%. As a key player..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Closer Look at Its 36.49% Potential Upside

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case for investors with its notable potential upside of 36.49%. As a key player in the healthcare sector, particularly within the specialty..

BioLife Solutions, Inc. (BLFS): Analyst Consensus Signals 45.95% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) is a name that has been generating considerable buzz in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in Bothell, Washington,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds